Trudy Lieberman
Contributing Editor
Contributing Editor
Trudy Lieberman, a journalist for more than 45 years, is a past president of the Association of Health Care Journalists and an adjunct professor of public health at the CUNY School of Public Health. She is a long-time contributor to the Columbia Journalism review where she blogs for CJR.org about media coverage of healthcare and retirement issues. She also blogs for Health News Review and writes a bi-monthly column, “Thinking About Health,” for the Rural Health News Service. She was a fellow at the Center for Advancing Health and regularly contributed to its Prepared Patient blog. She had a long career at Consumer Reports specializing in insurance, healthcare financing, and long-term care and began her career as a consumer writer for the Detroit Free Press. She has won 26 national and regional awards including two National Magazine Awards and has received five fellowships, including three Fulbright scholar and specialist awards. Ms. Lieberman is the author of five books including “Slanting the Story—the Forces That Shape the News,” and has served on the board of the Medicare Rights Center and the National Committee for Quality Assurance. She currently serves as a member of the National Advisory Committee for the California Health Benefits Review Program.
Is the government serious about attacking super-high drug prices by paying only for those with proven benefit for patients? The Aduhelm decision will be a critical tell.
Sustained coverage on surprise bills fueled public outrage and legislation. But the resulting regulations are far from perfect.
A trio of reporters offer a masterful examination of the overuse, underuse and misuse of medical care in America.
Comparing Medicare plans proves tough sledding — even for a veteran journalist tracking such plans for decades.
Why Medicare advocates worry deeply about any moves that erode the program’s universal reach among seniors.
If drug price negotiation fails, Democrats lose funding for much of their current health care plans.
While hospitals often deflect blame to other sectors of health care, there’s no question they play an outsized role in rising costs.
The media has largely taken a pass on covering the dark side of Medicare Advantage plans, so people don't understand how the plans’ cost-sharing and provider networks really work.
The media, the medical community, and academic drug experts all quickly questioned the FDA’s approval process — a rare occurrence.
Plans for adding a public option to the Affordable Care Act have stalled as the president punts the issue to Congress.